Author

Jennie H. Law

Observed names: J Law, Jennie Law

Institutions: Mayo Clinic, Emory University

Observed institutions: Mayo Clinic, University of British Columbia, Emory University

OpenAlex ID: A5007107585

Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass

2013 · Meera Shah, Jennie H. Law, et al. · Diabetes · 138

High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial

2012 · Jessica A Alvarez, Jennie Law, et al. · American Journal of Clinical Nutrition · 111

The Effect of a Bile Acid Sequestrant on Glucose Metabolism in Subjects With Type 2 Diabetes

2012 · Galina Smushkin, Matheni Sathananthan, et al. · Diabetes · 86

Symptomatic Amyloid Goiters: Report of Five Cases

2013 · Jennie H. Law, Diana S. Dean, et al. · Thyroid · 24

A Novel T Cell Receptor Transgenic Animal Model of Seborrheic Dermatitis-Like Skin Disease

2005 · Darryl A. Oble, Elisabeth Collett, et al. · Journal of Investigative Dermatology · 24

Methotrexate Update: Mechanism of Action in Psoriasis Therapy

2008 · Jennie H. Law, Bonnie Koo, et al. · Psoriasis Forum · 9

Effects of high‐dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease

2013 · Jessica A Alvarez, Susu M Zughaier, et al. · The FASEB Journal · 2

Erratum: Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease

2013 · J A Alvarez, S M Zughaier, et al. · European Journal of Clinical Nutrition · 1

A prospective, randomized, placebo‐controlled trial of high‐dose vitamin D for prevention of vitamin D insufficiency in early stage chronic kidney disease

2012 · Jessica A Alvarez, Jennie Law, et al. · The FASEB Journal

Works count: 9

Citation count: 395

H-index: 6

I10-index: 5